MKC8866

MKC8866
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T15594-1mg 1 mg -

7 - 10 business days*

78.00€
TGM-T15594-5mg 5 mg -

7 - 10 business days*

192.00€
TGM-T15594-1mL 1 ml -

7 - 10 business days*

208.00€
TGM-T15594-10mg 10 mg -

7 - 10 business days*

313.00€
TGM-T15594-25mg 25 mg -

7 - 10 business days*

527.00€
TGM-T15594-50mg 50 mg -

7 - 10 business days*

763.00€
TGM-T15594-100mg 100 mg -

7 - 10 business days*

1,069.00€
TGM-T15594-500mg 500 mg -

7 - 10 business days*

2,139.00€
 
Description: MKC8866 is a selective IRE1 RNase inhibitor (IC50: 0.29 µM in human vitro). MKC8866... more
Product information "MKC8866"
Description: MKC8866 is a selective IRE1 RNase inhibitor (IC50: 0.29 µM in human vitro). MKC8866 inhibits IRE1 RNase in breast cancer cells leading to the decreased production of pro-tumorigenic factors and it can inhibit prostate cancer (PCa) tumor growth. Target: IRE1. Smiles: COc1cc2c(C)c(CC(=O)N3CCOCC3)c(=O)oc2c(C=O)c1O. References: Sheng X, et al. IRE1alpha-XBP1s pathway promotes prostate cancer by activating c-MYC signaling. Nat Commun. 2019 Jan 24,10(1):323.
Supplier: TargetMol
Supplier-Nr: T15594

Properties

Application: IRE1alpha RNase activity inhibitor
MW: 361.35 D
Formula: C18H19NO7

Database Information

CAS : 1338934-59-0| Matching products
KEGG ID : K08852 | Matching products

Handling & Safety

Storage: +4°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "MKC8866"
Write a review
or to review a product.
Viewed